Find information on thousands of medical conditions and prescription drugs.

Cefotetan

Cefotetan is an injectable antibiotic of the cephamycin type for prophylaxis and treatment of bacterial infections. It is a second generation cephalosporin that has some anaerobe converage.

Cefotetan was developed by Yamanouchi. It is marketed outside Japan by AstraZeneca with the brand names Apatef and Cefotan.

A

B

C

Calcium folinate

Chenodeoxycholic acid

Chloramphenicol

Chlordiazepoxide

Chlorprothixene

Chlortetracycline

Choriogonadotropin alfa

Chorionic gonadotropin

Clavulanic acid

Cyclobenzaprine

Cyclophosphamide

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

X

Y

Z

Read more at Wikipedia.org

• [List your site here Free!]


		Cefotetan, a long-acting antibiotic $44.00			LODE CEFOTETAN CSD


	Cefotetan-induced hemolytic anemia: A case report and review of the literature Cefotetan disodium-induced hemolytic anemia has been reported previously, and some of these cases have been severe or fatal. We describe a case of severe ... From Archives of Pathology & Laboratory Medicine, 9/1/00 by Moes, Gregory Scott

	Cefotetan and cefoxitin in treatment of endometritis - Tips from Other Journals Cefotetan and cefoxitin, commonly used to treat endometritis, are broad-spectrum antibiotics active against both aerobic and anaerobic gram-positive ... From American Family Physician, 2/15/93

	Phenotypic characteristics of clinical isolates of Klebsiella pneumoniae & evaluation of available phenotypic techniques for detection of extended Background & objectives: Identifying organisms that harbour extended spectrum beta lactamases (ESBLs) is a major challenge for a diagnostic clinical microbiology ... From Indian Journal of Medical Research, 10/1/05 by Manchanda, Vikas

	Extended-spectrum beta-lactamases producing klebsiella pneumoniae infection, risk factors, antibiotic use and background PURPOSE: The development of multi-drug resistant bacterial infections is a serious problem in many hospitals. This study was conducted to identify the ... From CHEST, 10/1/05 by Frew H. Gebreab

	Extended-spectrum [beta]-lactamase-producing flora in healthy persons To the Editor: Extended-spectrum [beta]-lactamase (ESBL) producing gram-negative bacilli are endemic in hospitals. In intensive care units, 2% prevalence ... From Emerging Infectious Diseases, 6/1/05 by Camilla Rodrigues

	Antibiotic prophylaxis for surgery: advisory statement It is estimated that 2 to 5 percent of extra-abdominal surgeries and as many as 20 percent of intra-abdominal surgeries are complicated by a surgical ... From American Family Physician, 3/15/05 by Bill Zepf

	Anti-infective agents for intra-abdominal infections The Infectious Diseases Society of America, the Surgical Infection Society, the American Society for Microbiology, and the Society of Infectious Disease ... From American Family Physician, 5/1/04

	Bacterial resistance: how to detect three types CONTINUING EDUCATION To earn CEUs, see test on page 24. LEARNING OBJECTIVES Upon completion of this article the reader will be able to: 1. Discuss ... From Medical Laboratory Observer, 4/1/04 by Susan M. Shima

Home

Contact

Resources

ebay